Correlation Between Leap Therapeutics and Catalent

Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Catalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Catalent into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Leap Therapeutics and Catalent, you can compare the effects of market volatilities on Leap Therapeutics and Catalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Catalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Catalent.

Diversification Opportunities for Leap Therapeutics and Catalent

0.0

Correlation Coefficient

Leap Therapeutics  Catalent

Pay attention - limited upside

The 3 months correlation between Leap and Catalent is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Catalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalent and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Catalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalent has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Catalent go up and down completely randomly.

Pair Corralation between Leap Therapeutics and Catalent

If you would invest (100.00) in Catalent on November 28, 2024 and sell it today you would earn a total of  100.00  from holding Catalent or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Leap Therapeutics  vs.  Catalent

Leap Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Leap Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Catalent

Risk-Adjusted Performance

Very Weak

Over the last 90 days Catalent has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Catalent is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Leap Therapeutics and Catalent

The main advantage of trading using opposite Leap Therapeutics and Catalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Catalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will offset losses from the drop in Catalent's long position.

The idea behind Leap Therapeutics and Catalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.